Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial

AIMS: Most cardiac surgery patients, with or without diabetes, develop perioperative hyperglycaemia, for which intravenous insulin is the only therapeutic option. This is labour‐intensive and carries a risk of hypoglycaemia. We hypothesized that preoperative administration of the glucagon‐like pepti...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Diabetes Obes Metab
Main Authors: Hulst, Abraham H., Visscher, Maarten J., Godfried, Marc B., Thiel, Bram, Gerritse, Bastiaan M., Scohy, Thierry V., Bouwman, R. Arthur, Willemsen, Mark G. A., Hollmann, Markus W., Preckel, Benedikt, DeVries, J. Hans, Hermanides, Jeroen
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2019
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7079116/
https://ncbi.nlm.nih.gov/pubmed/31749275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13927
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki